Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001785982-20-000703
Filing Date
2020-08-07
Accepted
2020-08-07 21:52:31
Documents
49
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT sf0009h_10q.htm 10-Q 501451
2 EX 31.1 - CERTIFICATION sf0009h_ex31-1.htm EX-31 16151
3 EX 32.1 - CERTIFICATION sf0009h_ex32-1.htm EX-32 9742
  Complete submission text file 0001785982-20-000703.txt   3281732

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE bixt-20200630.xml EX-101.INS 626014
5 XBRL SCHEMA FILE bixt-20200630.xsd EX-101.SCH 36928
6 XBRL CALCULATION FILE bixt-20200630_cal.xml EX-101.CAL 30637
7 XBRL DEFINITION FILE bixt-20200630_def.xml EX-101.DEF 162595
8 XBRL LABEL FILE bixt-20200630_lab.xml EX-101.LAB 278938
9 XBRL PRESENTATION FILE bixt-20200630_pre.xml EX-101.PRE 226288
Mailing Address C/O BIOXYTRAN, INC. 233 NEEDHAM ST, SUITE 300 NEWTON MA 02464
Business Address C/O BIOXYTRAN, INC. 233 NEEDHAM ST, SUITE 300 NEWTON MA 02464 617-494-1199
BIOXYTRAN, INC (Filer) CIK: 0001445815 (see all company filings)

EIN.: 262797630 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35027 | Film No.: 201086858
SIC: 2834 Pharmaceutical Preparations